Creo Medical Group plc and internationally highly-ranked Khalifa University of Science and Technology in Abu Dhabi, have established a strategic collaboration to explore innovative commercial opportunities, with an initial focus on healthcare challenges relevant to the population in the United Arab Emirates (UAE), and the wider Middle East and North Africa region using the resources and expertise available at Khalifa University in Abu Dhabi to capitalise on Creo's Intellectual Property (IP) estate. Having recently performed first procedures in the UAE, Creo will also leverage the collaboration to support its regional distributors and core clinical operations, including the development of clinical research with key customers in Abu Dhabi and the wider region. This collaboration is aligned with Khalifa University's strategic objective to enhance enterprise targeted research with highly innovative partners.

Khalifa University's deep tech initiative encompasses research partnerships but also investments in start-ups, incubation services, a science and technology park, an endowment fund, and a continuing education programme. This collaboration is also in line with the UAE Government's policy and helps further Khalifa University's ambition to become one of the world's premier research institutions.